18-hydroxyoctadecanoic acid

18-hydroxyoctadecanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 115 references associated with 18-hydroxyoctadecanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 18-hydroxyoctadecanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 18-hydroxyoctadecanoic acid

MeSH term MeSH ID Detail
Celiac Disease D002446 16 associated lipids
Total 1

NCBI Entrez Crosslinks

All references with 18-hydroxyoctadecanoic acid

Download all related citations
Per page 10 20 50 | Total 31
Authors Title Published Journal PubMed Link
Frankel EN et al. Analysis of autoxidized fats by gas chromatography-mass spectrometry: I. Methyl oleate. 1977 Lipids pmid:927042
Sannolo N et al. [Extraction of fecal lipids and identification of hydroxystearic acid by gas chromatography-mass spectrometry (GC/MS)]. 1981 Boll. Soc. Ital. Biol. Sper. pmid:7248104
Pearson JR et al. Proceedings: The role of faecal flora in the production of hydroxystearic acid. 1973 Gut pmid:4758706
Thomas PJ Identification of some enteric bacteria which convert oleic acid to hydroxystearic acid in vitro. 1972 Gastroenterology pmid:4622161
Wiggins HS et al. Incidence and significance of faecal hydroxystearic acid in alimentary disease. 1974 Gut pmid:4418840
pmid:22339649
Chen Q et al. A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease. 2011 PLoS ONE pmid:22194796
Jeong CW et al. Lipid-emulsion propofol less attenuates the regulation of body temperature than micro-emulsion propofol or sevoflurane in the elderly. 2012 Yonsei Med. J. pmid:22187253
Varshosaz J et al. Lipid nanocapsule-based gels for enhancement of transdermal delivery of ketorolac tromethamine. 2011 J Drug Deliv pmid:22175029
Patel J et al. Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. 2011 J Adv Pharm Technol Res pmid:22171286
Ramadan A et al. Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. 2011 Int J Nanomedicine pmid:22162653
pmid:21463666
Vanpouille-Box C et al. Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model. 2011 PLoS ONE pmid:21408224
Chung DH et al. The effect and optimal dose of sufentanil in reducing injection pain of microemulsion propofol. 2011 Korean J Anesthesiol pmid:21390162
Kim HS et al. Prevention of pain during injection of microemulsion propofol: application of lidocaine mixture and the optimal dose of lidocaine. 2010 Korean J Anesthesiol pmid:21179291
Vandamme TF and Anton N Low-energy nanoemulsification to design veterinary controlled drug delivery devices. 2010 Int J Nanomedicine pmid:21042549
pmid:20945136
Paillard A et al. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. 2010 Biomaterials pmid:20630585
Han YK et al. Pain reduction on injection of microemulsion propofol via combination of remifentanil and lidocaine. 2010 Korean J Anesthesiol pmid:20532050
Kathir K et al. Equivalent lipid oxidation profiles in advanced atherosclerotic lesions of carotid endarterectomy plaques obtained from symptomatic type 2 diabetic and nondiabetic subjects. 2010 Free Radic. Biol. Med. pmid:20478379